机译:血清胱抑素C在多发性骨髓瘤中的预后意义
Department of Hematology, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany;
Department of Internal Medicine III, University of Ulm, Ulm, Germany;
Department of Internal Medicine, Rotes Kreuz Krankenhaus Bremen, Bremen, Germany;
Department of Clinical Chemistry, Medical Faculty, University of Duisburg-Essen, Essen, Germany;
Department of Clinical Chemistry, Medical Faculty, University of Duisburg-Essen, Essen, Germany;
Department of Internal Medicine III, University of Ulm, Ulm, Germany;
Department of Hematology, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany;
Department of Internal Medicine III, University of Ulm, Ulm, Germany;
Serum cystatin C; Prognostic marker; Multiple myeloma;
机译:血清胱抑素C在多发性骨髓瘤中的预后意义。
机译:多发性骨髓瘤中红细胞沉降率(ESR),血清白介素6(IL-6)和急性期蛋白水平的临床和预后意义。
机译:慢性肾脏病流行病学协作胱抑素C(CKD-EPI-CysC)方程对新诊断的有症状多发性骨髓瘤患者的总体生存具有独立的预后价值;是时候从MDRD更改为CKD-EPI-CysC方程了吗?
机译:多发性骨髓瘤患者血清血清蛋白二次结构分析
机译:确定血小板因子4(PF4)的生物学意义,PF4是编码多发性骨髓瘤中血管生成抑制剂的肿瘤抑制基因。
机译:循环血清microRNAs作为多发性骨髓瘤和单克隆丙种球蛋白病的新型诊断和预后生物标志物尚无定论
机译:多发性骨髓瘤治疗前初始血清白蛋白和24小时每日蛋白质排泄的预后意义。